Table 1.
Clinical characteristics of participants in this study.
| MR N = 538 | MU N = 529 | PR N = 765 | PU N = 675 | p value | |
|---|---|---|---|---|---|
| Gender (Male) | 231 (42.94%) | 179 (33.84%) | 274 (35.82%) | 232 (34.37%) | 0.005 |
| Age | 53.0 [44.0-63.0] | 49.0 [40.0-63.0] | 53.00 [45.0-62.0] | 55.0 [45.5-63.0] | <0.001 |
| Body mass index | 24.03 [22.03-26.43] | 24.77 [22.51-26.90] | 25.48 [23.35-27.78] | 25.00 [22.43-27.44] | <0.001 |
| Diabetes | 32 (5.95%) | 40 (7.56%) | 69 (9.02%) | 94 (13.93%) | <0.001 |
| Dyslipidemia | 156 (29.00%) | 181 (34.22%) | 517 (67.58%) | 445 (65.93%) | <0.001 |
| Hypertension | 186 (35.09%) | 209 (40.12%) | 260 (34.48%) | 189 (28.38%) | <0.001 |
| Fatty liver disease | 49 (9.11%) | 112 (21.17%) | 259 (33.86%) | 231 (34.22%) | <0.001 |
MR, Mountain rural; MU, Mountain urban; PR, Plain rural; PU, Plain urban. Categorical data are presented as numbers with percentages in round parentheses and were tested using the chi-square test or Fisher’s exact test. Continuous data are presented as median and interquartile range in squared parentheses and were tested using the Kruskal-Wallis H test. P values < 0.05 were considered statistically significant.